Fourth, in accordance with the findings in our study in obese patients with type 2 diabetes, others observed that GLP-1 administration at physiological levels in healthy obese men (without diabetes) resulted in decreased ratings of hunger and prospective food consumption [44]. The gene discussed is GCG; the disease is type 2 diabetes mellitus.